Citations

Mayo Clinic

Showing 10 of 108572 citations.

The Use of Pupillometry to Study Mental Demand during Speech Production in Noise
Coster, Elisabeth, Ishikawa, Keiko , Li, H., Orbelo, Diana M.

Proceedings of the 10th Convention of the European Acoustics Association Forum Acusticum 2023 | January 19, 2024 | Volume: No volume available | Issue: No issue available | Pages: 2793-2799

10.61782/fa.2023.0929 Get It

Exploring Automated Detection of Barrett’s Esophagus via Machine Modeling and Acoustic Analysis
Kamboj, Amrit K. , Yarlagadda, Manoj, Buller, K., Pietrowicz, Mary , Ishikawa, Keiko , Orbelo, Diana M. , Leggett, Cadman L.

Proceedings of the 10th Convention of the European Acoustics Association Forum Acusticum 2023 | January 19, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1355-1360

10.61782/fa.2023.0922 Get It

How I do it: a standardized approach to robotic‐assisted oncological sigmoid resection – a video vignette
Giron, Héloïse, Kefleyesus, Amaniel , Grass, F , Larson, David W. , Grass, Fabian

Colorectal Disease | January 19, 2024 | Volume: 26 | Issue: 3 | Pages: 578-579

10.1111/codi.16881 | PMID 38240160 Get It

Developing a Machine-Learning Model for Detecting Intelligibility Differences in Individuals with Voice Disorders: A Feasibility Study
Kamboj, Amrit K. , Yarlagadda, Manoj, Buller, K., Charney, Sara , Pietrowicz, Mary , Orbelo, Diana M. , Leggett, Cadman L. , Ishikawa, Keiko

Proceedings of the 10th Convention of the European Acoustics Association Forum Acusticum 2023 | January 19, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1875-1882

10.61782/fa.2023.0766 Get It

Proceedings of the 28th Annual Congress of the International Liver Transplantation Society
Mathew, Johns Shaji , Shingina, Alexandra , Khan, Mohammad Qasim , Wilson, Elizabeth A. , Alconchel, Felipe , Hakeem, Abdul , Shankar, Sadhana , Patel, Dhupal , Keskin, Onur , Mazzola, Alessandra , Tanaka, Tomohiro , Victor, David W. , Yoon, Uzung , Vinaixa, Carmen , Kirchner, Varvara A. , Martin, Eléonora De , Ghobrial, R. Mark , Wilson, Elizabeth , Rammohan, Ashwin , Alconchel, Felipe , Hakeem, Abdul Rahman , Shankar, Sadhana , Patel, Dhupal , Keskin, Onur , Nasralla, David , Mazzola, Alessandra , Tanaka, Tomohiro , Victor, David , Yoon, Uzung , Yoon, Young-In , Vinaixa, Carmen , Kirchner, Varvara , De Martin, Eleonora , Ghobrial, Mark , Chadha, Ryan , Syn, Nicholas L. X. , Liu, Jiang , Patel, Madhukar S. , Chadha, Ryan , Khan, Mohammad Qasim

Liver Transplantation | January 19, 2024 | Volume: 30 | Issue: 5 | Pages: 544-554

10.1097/lvt.0000000000000330 | PMID 38240602 Get It

The 2023 Joint International Congress of the International Liver Transplantation Society (ILTS), the European Liver and Intestine Transplant Association (ELITA), and the Liver Intensive Care Group of Europe (LICAGE) held in Rotterdam, the Netherlands, marked a significant recovery milestone for the liver transplant community after COVID-19. With 1159 participants and a surge in abstract submissions, the event focused on “Liver Disorders and Transplantation: Innovations and Evolving Indications.” This conference report provides a comprehensive overview of the key themes discussed during the event, encompassing Hepatology, Anesthesia and Critical Care, Acute Liver Failure, Infectious Disease, Immunosuppression, Pediatric Liver Transplantation, Living Donor Liver Transplantation, Transplant Oncology, Surgical Approaches, and Machine Perfusion. The congress provided a platform for extensive discussions on a wide range of topics, reflecting the continuous advancements and collaborative efforts within the liver transplant community.
Assessing the Cognitive Load of Talking in Whispers and Clear Speech with a Modified Simon Task
Kirkham, Catherine, Samenuk, J., Ishikawa, Keiko , Kirkham, C., Weaver, Richard Lee , Orbelo, Diana M.

Proceedings of the 10th Convention of the European Acoustics Association Forum Acusticum 2023 | January 19, 2024 | Volume: No volume available | Issue: No issue available | Pages: 2451-2456

10.61782/fa.2023.0562 Get It

Futility and poor outcomes are not the same thing: A clinical perspective of refined outcomes definitions in liver transplantation
Rolak, Stacey , Elhawary, Ahmed , Diwan, Tayyab S. , Watt, Kymberly D. , Diwan, Tayyab

Liver Transplantation | January 19, 2024 | Volume: 30 | Issue: 4 | Pages: 421-430

10.1097/lvt.0000000000000331 | PMID 38240612 Get It

The term “futility” in liver transplantation is used inappropriately and inaccurately, as it is frequently applied to patient populations with suboptimal outcomes that are often not truly “futile.” The term “futile” is used interchangeably with poor outcomes. Not all poor outcomes fulfill a definition of futility when considering all viewpoints. Definitions of “futility” are variable throughout the medical literature. We review futility in the context of liver transplantation, encompassing various viewpoints, with a goal to propose focused outcome definitions, including futility, that encompass broader viewpoints, and improve the utilization of “futility” to truly futile situations, and improve communication between providers and patients/families. Focused, appropriate definitions will help the transplant community develop better models to more accurately predict and avoid futile transplants, and better predict an individual patient’s posttransplant outcome.
2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia
Chaudhuri, Dipayan , Balk, R.A. , Asehnoune, Karim , Cadena, Rhonda, Carcillo, Joseph A. , Drover, Katherine, Esper, Annette , Hammond, Naomi , Jayaprakash, Namita , Menon, Kusum , Nazer, Lama , Pitre, Tyler, Qasim, Zaffer , Russell, James A. , Santos, Ariel , Tilouche, Nejla, Nei, Andrea M. , Hammond, Naomi , Rochwerg, Bram , Correa, Ricardo, Drover, Katherine, Gershengorn, Hayley Beth , Sarwal, Aarti , Spencer-Segal, Joanna L. , Annane, Djillali , Pastores, Stephen M.

Critical Care Medicine | January 19, 2024 | Volume: 52 | Issue: 5 | Pages: e219-e233

10.1097/ccm.0000000000006172 | PMID 38240492 Get It

RATIONALE: New evidence is available examining the use of corticosteroids in sepsis, acute respiratory distress syndrome (ARDS) and community-acquired pneumonia (CAP), warranting a focused update of the 2017 guideline on critical illness-related corticosteroid insufficiency. OBJECTIVES: To develop evidence-based recommendations for use of corticosteroids in hospitalized adults and children with sepsis, ARDS, and CAP. PANEL DESIGN: The 22-member panel included diverse representation from medicine, including adult and pediatric intensivists, pulmonologists, endocrinologists, nurses, pharmacists, and clinician-methodologists with expertise in developing evidence-based Clinical Practice Guidelines. We followed Society of Critical Care Medicine conflict of interest policies in all phases of the guideline development, including task force selection and voting. METHODS: After development of five focused Population, Intervention, Control, and Outcomes (PICO) questions, we conducted systematic reviews to identify the best available evidence addressing each question. We evaluated the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach and formulated recommendations using the evidence-to-decision framework. RESULTS: In response to the five PICOs, the panel issued four recommendations addressing the use of corticosteroids in patients with sepsis, ARDS, and CAP. These included a conditional recommendation to administer corticosteroids for patients with septic shock and critically ill patients with ARDS and a strong recommendation for use in hospitalized patients with severe CAP. The panel also recommended against high dose/short duration administration of corticosteroids for septic shock. In response to the final PICO regarding type of corticosteroid molecule in ARDS, the panel was unable to provide specific recommendations addressing corticosteroid molecule, dose, and duration of therapy, based on currently available evidence. CONCLUSIONS: The panel provided updated recommendations based on current evidence to inform clinicians, patients, and other stakeholders on the use of corticosteroids for sepsis, ARDS, and CAP.
Artificial Intelligence–Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application
Chara, Beatriz Sordi , Hara, Kamalpreet S. , Schmidt, Kathryn A. , Kassmeyer, Blake A., Anstey, Jacob, Tiede, David, Kamath, Patrick S. , Shah, Vijay H. , Bajaj, Jasmohan S. , Kraus, Asaf, Sordi Chara, Beatriz , Penrice, Daniel , Kamath, Patrick S , Bajaj, Jasmohan S , Penrice, Daniel D. , Simonetto, Douglas A.

American Journal of Gastroenterology | January 19, 2024 | Volume: 119 | Issue: 5 | Pages: 982-986

10.14309/ajg.0000000000002656 | PMID 38240303 Get It

INTRODUCTION: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence–enabled tool to guide lactulose use through a smartphone application. METHODS: Subjects with hepatic encephalopathy on lactulose captured bowel movement pictures during lead-in and intervention phases. During the intervention phase, daily feedback on lactulose titration was delivered through the application. Goals were determined according to number of bowel movement and Bristol Stool Scale reports. RESULTS: Subjects completed the study with more than 80% satisfaction. In the lead-in phase, less compliant subjects achieved Bristol Stool Scale goal on 62/111 (56%) of days compared with 107/136 (79%) in the intervention phase ( P = 0.041), while the most compliant subjects showed no difference. Severe/recurrent hepatic encephalopathy group achieved Bristol Stool Scale goal on 80/104 (77%) days in the lead-in phase and 90/110 (82%) days in the intervention phase ( P = NS), compared with 89/143 (62%) days and 86/127 (68%) days in the stable group. DISCUSSION: Dieta application is a promising tool for objective Bowel Movement/Bristol Stool Scale tracking for hepatic encephalopathy and may potentially be used to assist with lactulose titration.
Artificial Intelligence of Arterial Doppler Waveforms to Predict Major Adverse Outcomes Among Patients Evaluated for Peripheral Artery Disease
McBane, Robert D. , Murphree, Dennis H. , Liedl, David , López-Jiménez, Francisco , Attia, Zachi I. , Arruda‐Olson, Adelaide M. , Scott, Christopher G. , Prodduturi, Naresh, Nowakowski, Steve E., Rooke, Thom W. , Wennberg, Paul W. , Attia, Zachi I , Casanegra, Ana I , Houghton, Damon E , Bjarnason, Haraldur , McBane, Robert , Scott, Christopher , Lopez-Jimenez, Francisco , Casanegra, Ana I. , Wysokiński, Waldemar E. , Houghton, Damon E. , Bjarnason, Haraldur

Journal of the American Heart Association | January 19, 2024 | Volume: 13 | Issue: 3 | Pages: No page available

10.1161/jaha.123.031880 | PMID 38240202 Get It

Background Patients with peripheral artery disease are at increased risk for major adverse cardiac events, major adverse limb events, and all‐cause death. Developing tools capable of identifying those patients with peripheral artery disease at greatest risk for major adverse events is the first step for outcome prevention. This study aimed to determine whether computer‐assisted analysis of a resting Doppler waveform using deep neural networks can accurately identify patients with peripheral artery disease at greatest risk for adverse outcome events. Methods and Results Consecutive patients (April 1, 2015, to December 31, 2020) undergoing ankle–brachial index testing were included. Patients were randomly allocated to training, validation, and testing subsets (60%/20%/20%). Deep neural networks were trained on resting posterior tibial arterial Doppler waveforms to predict major adverse cardiac events, major adverse limb events, and all‐cause death at 5 years. Patients were then analyzed in groups based on the quartiles of each prediction score in the training set. Among 11 384 total patients, 10 437 patients met study inclusion criteria (mean age, 65.8±14.8 years; 40.6% women). The test subset included 2084 patients. During 5 years of follow‐up, there were 447 deaths, 585 major adverse cardiac events, and 161 MALE events. After adjusting for age, sex, and Charlson comorbidity index, deep neural network analysis of the posterior tibial artery waveform provided independent prediction of death (hazard ratio [HR], 2.44 [95% CI, 1.78–3.34]), major adverse cardiac events (HR, 1.97 [95% CI, 1.49–2.61]), and major adverse limb events (HR, 11.03 [95% CI, 5.43–22.39]) at 5 years. Conclusions An artificial intelligence–enabled analysis of Doppler arterial waveforms enables identification of major adverse outcomes among patients with peripheral artery disease, which may promote early adoption and adherence of risk factor modification.